OptimizeRx (OPRX) investor relations material

Corporate profile and market position

• Leading provider of technology solutions connecting life sciences, physicians, and patients to improve therapy adherence.

• Operates the largest patient point-of-care network in the U.S., reaching most physicians and patients.

• Employs about 130 staff across the U.S. and Croatia, with revenue per FTE exceeding $800K.

• Listed on NASDAQ with a market cap of ~$111.3M, $23.4M in cash, and $25.7M in debt as of early 2026.

Technology and platform capabilities

• Dynamic Audience Activation Platform (DAAP) delivers predictive, privacy-safe marketing across clinical and personal platforms.

• Platform connects over 2 million healthcare professionals and 240 million patients, integrating with 300+ EHRs.

• DAAP supports ~350 brands, covering 45% of the top 200 brands, with only 10% solution penetration.

• DAAP deals typically range from $0.5M to $1.5M, leveraging AI for targeted marketing execution.

Market opportunity and growth drivers

• U.S. pharma digital ad spend projected to reach $21.6B by 2026, with pharma accounting for nearly 90% of industry digital ad spending.

• Current DAAP opportunity with existing brands estimated at $2B–$3B.

• Platform addresses key pharma challenges: brand visibility, specialty medication shift, EHR overload, affordability, interoperability, and script abandonment.